Amneal Takes New Execs From Alvotech And FDA
Malki Joins As Quality Chief While Toufanian Heads Regulatory Strategy And Policy
Amneal has looked to biosimilars developer Alvotech and the US FDA’s Office of Generic Drugs for its latest executive appointments, with Reem Malki joining the US firm as chief quality officer and Maryll Toufanian becoming head of regulatory strategy and policy.
